Catalyst
Slingshot members are tracking this event:
ALKS study of ALKS 3831 on olanzapine associated weight gain related to schizophrenia expected to complete in the first half of 2018
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| ALKS |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 26, 2018
Occurred Source:
http://phx.corporate-ir.net/phoenix.zhtml?c=92211&p=irol-corporateNewsArticle&ID=2344850
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Alks-3831, Olanzapine, Weight Gain
